Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
5(22%)
Results Posted
7%(1 trials)

Phase Distribution

Ph not_applicable
1
4%
Ph phase_3
1
4%
Ph phase_4
2
9%
Ph phase_2
3
13%
Ph phase_1
15
65%

Phase Distribution

15

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
15(68.2%)
Phase 2Efficacy & side effects
3(13.6%)
Phase 3Large-scale testing
1(4.5%)
Phase 4Post-market surveillance
2(9.1%)
N/ANon-phased studies
1(4.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

23

all time

Status Distribution
Active(5)
Completed(15)
Other(3)

Detailed Status

Completed15
Recruiting4
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 115 (68.2%)
Phase 23 (13.6%)
Phase 31 (4.5%)
Phase 42 (9.1%)
N/A1 (4.5%)

Trials by Status

active_not_recruiting14%
unknown313%
completed1565%
recruiting417%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06485505Phase 1

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

Recruiting
NCT07283497Phase 4

Itraconazole Therapy In Bronchiectasis With Airway Mold

Recruiting
NCT07342153Phase 4

Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis

Recruiting
NCT06399315Phase 1

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

Completed
NCT06787131Phase 1

Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

Completed
NCT06677996Phase 1

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

Completed
NCT04824417Phase 3

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

Completed
NCT06379958Phase 1

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Recruiting
NCT05482763

Mycosis Culture Collection From Dermatological Isolated

Active Not Recruiting
NCT05902728Phase 1

Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

Completed
NCT05602597Phase 1

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

Completed
NCT05684718Phase 1

To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100

Completed
NCT04942652Phase 1

Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers

Completed
NCT02706535Phase 1

A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential

Completed
NCT03103646Phase 1

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women

Completed
NCT03972748Not Applicable

Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

Unknown
NCT03664115Phase 2

Itraconazole in Non Small Cell Lung Cancer

Unknown
NCT03479411Phase 1

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

Completed
NCT03498170Phase 1

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Completed
NCT03471455Phase 2

Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
23